Jim Lang, MBA, is the founder and CEO of EVERSANA™ which in just three short years has become the leading provider of global commercialization services to the life science industry. The company’s 3000+ employees serve over 600 life science organizations, including all top 25 biopharma. Under Mr. Lang’s leadership, EVERSANA™ will launch more biopharma products in each of the next few years than any other company. He formerly served as the CEO of Decision Resources Group (DRG). During his tenure, he transformed DRG into a leading healthcare data and analytics firm. Previously Mr. Lang was President of Strategic Decision Group (SDG) where he expanded the life sciences practice and later sold it to IQVia. He has served on numerous private and public boards, currently including HCIT leader OptimizeRx (OPRX). He has provided investment and guided the development of multiple early-stage healthcare companies including Boston Heart Labs and AlphaImpactRx. He holds a BS in electrical and computer engineering from the University of New Hampshire, and an MBA from the Tuck School of Business at Dartmouth. Mr. Lang was honored by PharmaVoice in 2020 as one of the “100 most inspiring people” in the industry.